Company Presentation Schedule

Diakonos Oncology is a clinical-stage biotechnology company, developing a novel "Double-Loaded" Dendritic Cell Vaccine (DCV) for the treatment of Glioblastoma Multiforme (GBM) as well as other difficu ...

Company Description: Craif has developed a miRNA platform and proprietary sampling technology that allows the capture of lower expression RNA in order to develop assays that can accurately predict a p ...

Panavance Therapeutics Inc. is a privately-held, clinical-stage pharmaceutical company developing a novel oncology platform focused on improving the outcomes and quality of life for patients. Panavanc ...

Company Description: Imagion Biosystems, Ltd. (ASX: IBX) is pioneering molecularly targeted MRI Contrast Agents with its MagSense® technology - a new functional imaging product line that holds the pro ...

Company Description: NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative power of nitric oxide (NO) to heal chronic wounds. NOxy ...

Biotech developing mRNA therapeutics to combat aging and age-related disease

Pacylex Pharmaceuticals is a Canadian oncology company in Phase 2 with a highly differentiated cancer therapy, zelenirstat (PCLX-001), a first in class, once-per-day oral medication that completely re ...

Company Description: Estrigenix Therapeutics is preclinical pharmaceutical development company pioneering therapies to improving women's health. Estrigenix was formed as a spinout of collaborative res ...

Osmol is an IND-stage biopharma company based in New Haven, CT, developing technology licensed from Yale School of Medicine to address chemotherapy induced peripheral neuropathy (CIPN). CIPN is a sign ...

ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s proprietary polymer technology reduces the immunogenicity of therapeutic prot ...

Aptah's molecule is the first and only compound that assures accurate RNA processing of multiple proteins. It works as a template for overall RNA quality control, altering the fate of diseased cells w ...

Company Description: NFlection is a clinical stage biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppres ...

Maipl has created an exceptionally potent small molecule prostaglandin PGF2α antagonist, MA-7107, that has exquisite selectivity, without interfering other essential prostaglandin functions. High leve ...

Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant on ...

LBL Biotec. Inc. is a spin-off company from National Cheng-kung University at Taiwan. The company focusses on the development of IL-20 antibody to treat several inflammation-associated diseases such a ...

Company Description: Shaperon Inc. is a clinical stage biotech company (KOSDAQ Ticker: 378800). It has 3 clinical stage assets. (1) Atopic Dermatitis: US FDA IND approval in September 2023. With its e ...

South Rampart Pharma, Inc. is a clinical-stage biotech company focused on addressing the critical need for a safe and effective approach to relieving pain. Its lead clinical candidate, SRP-001, is a n ...

Multimeric Biotherapeutics, Inc. is an early-stage, founder-backed company focused on stimulating immunity against cancer and infections. Its patented FortiVac technology elicits very strong CD8+ T ce ...

Company Description: First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Fi ...

Enzyme by Design is a preclinical stage biotech startup specializing in engineering highly effective and significantly safer cancer biologics.

Company Description: GATC Health is an AI company transforming drug development and disease prediction. Our proprietary Multiomics Advanced Technology™ (MAT) simulates complex human physiology for the ...

DIMERx is a platform company progressing an oral, non-addictive opioid analgesic for chronic pain through mid/late-stage clinical trials. DIMERx is developing DMX-101, a dimer of buprenorphine, for th ...

Company Description: Acoustic Bio is a Stanford University spin-out company focused on developing a platform to scale and accelerate screening of patient-derived organoids (PDOs) to advance personaliz ...

Company Description: Rebel Medicine is a specialty pharmaceutical company headquartered in Salt Lake City, Utah, that leverages drug delivery science to create innovative therapies to address unmet me ...

Company Description: Orphagen is a pioneer in discovery and development of small molecule drugs that modulate orphan or unexplored members of the nuclear receptor family, one of the most successful dr ...